Cargando…

Modulation of Cardiovascular Function in Primary Hypertension in Rat by SKA-31, an Activator of K(Ca)2.x and K(Ca)3.1 Channels

The aim of this study was to investigate the hemodynamic effects of SKA-31, an activator of the small (K(Ca)2.x) and intermediate (K(Ca)3.1) conductance calcium-activated potassium channels, and to evaluate its influence on endothelium-derived hyperpolarization (EDH)-K(Ca)2.3/K(Ca)3.1 type relaxatio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kloza, Monika, Baranowska-Kuczko, Marta, Toczek, Marek, Kusaczuk, Magdalena, Sadowska, Olga, Kasacka, Irena, Kozłowska, Hanna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6747311/ https://www.ncbi.nlm.nih.gov/pubmed/31450834 http://dx.doi.org/10.3390/ijms20174118

Ejemplares similares

Vasodilatory effects of cannabidiol in human pulmonary and rat small mesenteric arteries: modification by hypertension and the potential pharmacological opportunities
por: Baranowska-Kuczko, Marta, et al.
Publicado: (2020)

Vasoprotective Endothelial Effects of Chronic Cannabidiol Treatment and Its Influence on the Endocannabinoid System in Rats with Primary and Secondary Hypertension
por: Baranowska-Kuczko, Marta, et al.
Publicado: (2021)

Beneficial Changes in Rat Vascular Endocannabinoid System in Primary Hypertension and under Treatment with Chronic Inhibition of Fatty Acid Amide Hydrolase by URB597
por: Baranowska-Kuczko, Marta, et al.
Publicado: (2021)

K(Ca)3.1 Channels and Glioblastoma: In Vitro Studies
por: Klumpp, Lukas, et al.
Publicado: (2018)

Cancer-Associated Intermediate Conductance Ca(2+)-Activated K(+) Channel K(Ca)3.1
por: Mohr, Corinna J., et al.
Publicado: (2019)

K(Ca)2 and K(Ca)3.1 Channels in the Airways: A New Therapeutic Target
por: Orfali, Razan, et al.
Publicado: (2023)

Functional K(Ca)3.1 K(+) channels are required for human fibrocyte migration
por: Cruse, Glenn, et al.
Publicado: (2011)

Cannabidiol Improves Antioxidant Capacity and Reduces Inflammation in the Lungs of Rats with Monocrotaline-Induced Pulmonary Hypertension
por: Krzyżewska, Anna, et al.
Publicado: (2022)

Cannabidiol Ameliorates Monocrotaline-Induced Pulmonary Hypertension in Rats
por: Sadowska, Olga, et al.
Publicado: (2020)

Pulmonary Hypertension in Wild Type Mice and Animals with Genetic Deficit in K(Ca)2.3 and K(Ca)3.1 Channels
por: Wandall-Frostholm, Christine, et al.
Publicado: (2014)

The K(+) Channel K(Ca)3.1 as a Novel Target for Idiopathic Pulmonary Fibrosis
por: Roach, Katy Morgan, et al.
Publicado: (2013)

K(Ca)3.1 K(+) Channel Expression and Function in Human Bronchial Epithelial Cells
por: Arthur, Greer K., et al.
Publicado: (2015)

K(Ca)3.1 Channels Confer Radioresistance to Breast Cancer Cells
por: Mohr, Corinna J., et al.
Publicado: (2019)

Correction: The K(+) Channel K(Ca)3.1 as a Novel Target for Idiopathic Pulmonary Fibrosis
por: Roach, Katy M, et al.
Publicado: (2014)

Histone Deacetylases Enhance Ca(2+)-Activated K(+) Channel K(Ca)3.1 Expression in Murine Inflammatory CD4(+) T Cells
por: Matsui, Miki, et al.
Publicado: (2018)

Muscle Damage in Dystrophic mdx Mice Is Influenced by the Activity of Ca(2+)-Activated K(Ca)3.1 Channels
por: Morotti, Marta, et al.
Publicado: (2022)

Reduction of the serotonin 5-HT(1B) and 5-HT(2A) receptor-mediated contraction of human pulmonary artery by the combined 5-HT(1B) receptor antagonist and serotonin transporter inhibitor LY393558
por: Baranowska-Kuczko, Marta, et al.
Publicado: (2020)

Relaxation of human pulmonary arteries by PPARγ agonists
por: Kozłowska, Hanna, et al.
Publicado: (2013)

New Insights on the Voltage Dependence of the K(Ca)3.1 Channel Block by Internal TBA
por: Banderali, Umberto, et al.
Publicado: (2004)

Functional Roles of the Ca(2+)-activated K(+) Channel, KCa3.1, in Brain Tumors
por: D’Alessandro, Giuseppina, et al.
Publicado: (2018)

Functional expression of mitochondrial K(Ca)3.1 channels in non-small cell lung cancer cells
por: Bulk, Etmar, et al.
Publicado: (2022)

Synthesis and biological evaluation of PET tracers designed for imaging of calcium activated potassium channel 3.1 (K(Ca)3.1) channels in vivo
por: Brömmel, Kathrin, et al.
Publicado: (2021)

The feeding behaviour of Amyotrophic Lateral Sclerosis mouse models is modulated by the Ca(2+)‐activated K(Ca)3.1 channels
por: Cocozza, Germana, et al.
Publicado: (2021)

Modulation of K(Ca)3.1 Channels by Eicosanoids, Omega-3 Fatty Acids, and Molecular Determinants
por: Kacik, Michael, et al.
Publicado: (2014)

Imaging of K(Ca)3.1 Channels in Tumor Cells with PET and Small‐Molecule Fluorescent Probes
por: Thale, Insa, et al.
Publicado: (2022)

Internalization and Transportation of Endothelial Cell Surface K(Ca)2.3 and K(Ca)3.1 in Normal Pregnancy and Preeclampsia
por: Choi, Shinkyu, et al.
Publicado: (2019)

Human lung myofibroblast TGFβ1-dependent Smad2/3 signalling is Ca(2+)-dependent and regulated by K(Ca)3.1 K(+) channels
por: Roach, Katy M, et al.
Publicado: (2015)

Downregulation of IL-8 and IL-10 by the Activation of Ca(2+)-Activated K(+) Channel K(Ca)3.1 in THP-1-Derived M(2) Macrophages
por: Ohya, Susumu, et al.
Publicado: (2022)

K(Ca)3.1 Channel-Blockade Attenuates Airway Pathophysiology in a Sheep Model of Chronic Asthma
por: Van Der Velden, Joanne, et al.
Publicado: (2013)

Characterization and Chemical Synthesis of Cm39 (α-KTx 4.8): A Scorpion Toxin That Inhibits Voltage-Gated K(+) Channel K(V)1.2 and Small- and Intermediate-Conductance Ca(2+)-Activated K(+) Channels K(Ca)2.2 and K(Ca)3.1
por: Naseem, Muhammad Umair, et al.
Publicado: (2023)

Engagement of the EP(2) prostanoid receptor closes the K(+) channel K(Ca)3.1 in human lung mast cells and attenuates their migration
por: Duffy, S Mark, et al.
Publicado: (2008)

Downregulation of the Ca(2+)‐activated K(+) channel K(C) (a)3.1 by histone deacetylase inhibition in human breast cancer cells
por: Ohya, Susumu, et al.
Publicado: (2016)

Contribution of the Potassium Channels K(V)1.3 and K(Ca)3.1 to Smooth Muscle Cell Proliferation in Growing Collateral Arteries
por: Lasch, Manuel, et al.
Publicado: (2020)

Mechanisms of endothelium-dependent relaxation evoked by anandamide in isolated human pulmonary arteries
por: Baranowska-Kuczko, Marta, et al.
Publicado: (2014)

The Ca(2+)-Activated K(+) Channel KCa3.1 as a Potential New Target for the Prevention of Allograft Vasculopathy
por: Chen, Yi-Je, et al.
Publicado: (2013)

Synthesis of Small‐Molecule Fluorescent Probes for the In Vitro Imaging of Calcium‐Activated Potassium Channel K(Ca)3.1
por: Brömmel, Kathrin, et al.
Publicado: (2020)

Contradictory Effects of Superoxide and Hydrogen Peroxide on K(Ca)3.1 in Human Endothelial Cells
por: Choi, Shinkyu, et al.
Publicado: (2013)

Orai/CRACM1 and K(Ca)3.1 ion channels interact in the human lung mast cell plasma membrane
por: Duffy, S. Mark, et al.
Publicado: (2015)

Involvement of Ca(2+)-activated K(+) channel 3.1 in hypoxia-induced pulmonary arterial hypertension and therapeutic effects of TRAM-34 in rats
por: Guo, Shujin, et al.
Publicado: (2017)

Adenosine closes the K(+) channel K(Ca)3.1 in human lung mast cells and inhibits their migration via the adenosine A(2A) receptor
por: Duffy, S Mark, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_cjp287nsl253fenjkcou1n6bpe